The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Integrative Genome Comparison of Primary and Metastatic Melanomas
Open accessAbstract
A cardinal feature of malignant melanoma is its metastatic propensity. An incomplete view of the genetic events driving metastatic progression has been a major barrier to rational development of effective therapeutics and prognostic diagnostics for melanoma patients. In this study, we conducted global genomic characterization of primary and metastatic melanomas to examine the genomic landscape associated with metastatic progression. In addition to uncovering three genomic subclasses of metastastic melanomas, we delineated 39 focal and recurrent regions of amplification and deletions, many of which encompassed resident genes that have not been implicated in cancer or metastasis. To identify progression-associated metastasis gene candidates, we applied a statistical approach, Integrative Genome Comparison (IGC), to define 32 genomic regions of interest that were significantly altered in metastatic relative to primary melanomas, encompassing 30 resident genes with statistically significant expression deregulation. Functional assays on a subset of these candidates, including MET, ASPM, AKAP9, IMP3, PRKCA, RPA3, and SCAP2, validated their pro-invasion activities in human melanoma cells. Validity of the IGC approach was further reinforced by tissue microarray analysis of Survivin showing significant increased protein expression in thick versus thin primary cutaneous melanomas, and a progression correlation with lymph node metastases. Together, these functional validation results and correlative analysis of human tissues support the thesis that integrated genomic and pathological analyses of staged melanomas provide a productive entry point for discovery of melanoma metastases genes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Distinct Sets of Genetic Alterations in Melanoma
Curtin, J. A., Fridlyand, J., Kageshita, T., Patel, H. N., Busam, K. J., Kutzner, H., Cho, K.-H., Aiba, S., Bröcker, E.-B., LeBoit, P. E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050092 · Cited by 2,747
Circular binary segmentation for the analysis of array-based DNA copy number data
Olshen, A. B., Venkatraman, E. S., Lucito, R., & Wigler, M. (2004) · Biostatistics · doi:10.1093/biostatistics/kxh008 · Cited by 2,325
Metagenes and molecular pattern discovery using matrix factorization
Brunet, J.-P., Tamayo, P., Golub, T. R., & Mesirov, J. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308531101 · Cited by 2,183
Self-citationMolecular classification of cutaneous malignant melanoma by gene expression profiling
Bittner, M., Meltzer, P., Chen, Y., Jiang, Y., Seftor, E., Hendrix, M., Radmacher, M., Simon, R., Yakhini, Z., Ben-Dor, A., et al. (2000) · Nature · doi:10.1038/35020115 · Cited by 1,990
Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi
Van Raamsdonk, C. D., Bezrookove, V., Green, G., Bauer, J., Gaugler, L., O’Brien, J. M., Simpson, E. M., Barsh, G. S., & Bastian, B. C. (2009) · Nature · doi:10.1038/nature07586 · Cited by 1,623
Garraway, L. A., Widlund, H. R., Rubin, M. A., Getz, G., Berger, A. J., Ramaswamy, S., Beroukhim, R., Milner, D. A., Granter, S. R., Du, J., et al. (2005) · Nature · doi:10.1038/nature03664 · Cited by 1,548
Self-citationRac Activation and Inactivation Control Plasticity of Tumor Cell Movement
Sanz-Moreno, V., Gadea, G., Ahn, J., Paterson, H., Marra, P., Pinner, S., Sahai, E., & Marshall, C. J. (2008) · Cell · doi:10.1016/j.cell.2008.09.043 · Cited by 959
Survivin, versatile modulation of cell division and apoptosis in cancer
Altieri, D. C. (2003) · Oncogene · doi:10.1038/sj.onc.1207113 · Cited by 900
Genetic determinants of cancer metastasis
Nguyen, D. X., & Massagué, J. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2101 · Cited by 801
Onken, M. D., Worley, L. A., Ehlers, J. P., & Harbour, J. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1750 · Cited by 750
Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target
Horvath, S., Zhang, B., Carlson, M., Lu, K. V., Zhu, S., Felciano, R. M., Laurance, M. F., Zhao, W., Qi, S., Chen, Z., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608396103 · Cited by 641
Malignant melanoma: genetics and therapeutics in the genomic era
Chin, L., Garraway, L. A., & Fisher, D. E. (2006) · Genes & Development · doi:10.1101/gad.1437206 · Cited by 511
Self-citationGene Expression Profiling of Primary Cutaneous Melanoma and Clinical Outcome
Winnepenninckx, V., Lazar, V., Michiels, S., Dessen, P., Stas, M., Alonso, S. R., Avril, M.-F., Ortiz Romero, P. L., Robert, T., Balacescu, O., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj103 · Cited by 480
The gene expression signatures of melanoma progression
Haqq, C., Nosrati, M., Sudilovsky, D., Crothers, J., Khodabakhsh, D., Pulliam, B. L., Federman, S., Miller, J. R., Allen, R. E., Singer, M. I., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501564102 · Cited by 433
Carrasco, D. R., Tonon, G., Huang, Y., Zhang, Y., Sinha, R., Feng, B., Stewart, J. P., Zhan, F., Khatry, D., Protopopova, M., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.019 · Cited by 425
Self-citationHigh-resolution genomic profiles of human lung cancer
Tonon, G., Wong, K.-K., Maulik, G., Brennan, C., Feng, B., Zhang, Y., Khatry, D. B., Protopopov, A., You, M. J., Aguirre, A. J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504126102 · Cited by 394
Self-citationComparative Oncogenomics Identifies NEDD9 as a Melanoma Metastasis Gene
Kim, M., Gans, J. D., Nogueira, C., Wang, A., Paik, J.-H., Feng, B., Brennan, C., Hahn, W. C., Cordon-Cardo, C., Wagner, S. N., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.008 · Cited by 392
Self-citationCopy number variation at 1q21.1 associated with neuroblastoma
Diskin, S. J., Hou, C., Glessner, J. T., Attiyeh, E. F., Laudenslager, M., Bosse, K., Cole, K., Mossé, Y. P., Wood, A., Lynch, J. E., et al. (2009) · Nature · doi:10.1038/nature08035 · Cited by 354
GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer
Scott, K. L., Kabbarah, O., Liang, M.-C., Ivanova, E., Anagnostou, V., Wu, J., Dhakal, S., Wu, M., Chen, S., Feinberg, T., et al. (2009) · Nature · doi:10.1038/nature08109 · Cited by 349
Self-citationTschentscher, F., Hüsing, J., Hölter, T., Kruse, E., Dresen, I. G., Jöckel, K., Anastassiou, G., Schilling, H., Bornfeld, N., Horsthemke, B., et al. (2003) · PubMed · Cited by 323
Serra‐Pagès, C., Kedersha, N. L., Fazikas, L., Medley, Q., Debant, A., & Streuli, M. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07282.x · Cited by 321
Modeling Genomic Diversity and Tumor Dependency in Malignant Melanoma
Lin, W. M., Baker, A. C., Beroukhim, R., Winckler, W., Feng, W., Marmion, J. M., Laine, E., Greulich, H., Tseng, H., Gates, C., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2615 · Cited by 297
Self-citationStark, M., & Hayward, N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4152 · Cited by 237
Classification of Clear-Cell Sarcoma as a Subtype of Melanoma by Genomic Profiling
Segal, N. H., Pavlidis, P., Noble, W. S., Antonescu, C. R., Viale, A., Wesley, U. V., Busam, K., Gallardo, H., DeSantis, D., Brennan, M. F., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.108 · Cited by 197
Self-citationHoeflich, K. P., Herter, S., Tien, J., Wong, L., Berry, L., Chan, J., O'Brien, C., Modrusan, Z., Seshagiri, S., Lackner, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3563 · Cited by 174
Harada, T., Chelala, C., Bhakta, V, Chaplin, T., Caulee, K., Baril, P., Young, B. D., & Lemoine, N. R. (2008) · Oncogene · doi:10.1038/sj.onc.1210832 · Cited by 159
Luo, M., Shen, X., Zhang, Y., Wei, F., Xu, X., Cai, Y., Zhang, X., Sun, Y.-T., Zhan, Q., Wu, M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1484 · Cited by 153
Self-citationHigh-Resolution Global Profiling of Genomic Alterations with Long Oligonucleotide Microarray
Brennan, C. W., Zhang, Y., Leo, C., Feng, B., Cauwels, C., Aguirre, A. J., Kim, M., Protopopov, A. I., & Chin, L. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1241 · Cited by 150
Self-citationCutaneous melanoma: available therapy for metastatic disease
Tarhini, A. A., & Agarwala, S. S. (2006) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2005.00052.x · Cited by 149
Petersen, S., Aninat-Meyer, M., Schlüns, K., Gellert, K., Dietel, M., & Petersen, I. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0878 · Cited by 147
NEDD9 Promotes Oncogenic Signaling in Mammary Tumor Development
Izumchenko, E., Singh, M. K., Plotnikova, O. V., Tikhmyanova, N., Little, J. L., Serebriiskii, I. G., Seo, S., Kurokawa, M., Egleston, B. L., Klein–Szanto, A. J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0795 · Cited by 144
Weiss, M. M., Kuipers, E. J., Postma, C., Snijders, A. M., Pinkel, D., Meuwissen, S. G. M., Albertson, D. G., & Meijer, G. A. (2004) · Analytical Cellular Pathology · doi:10.1155/2004/454238 · Cited by 138
KiSS1 Suppresses Metastasis in Human Ovarian Cancer via Inhibition of Protein Kinase C Alpha
Jiang, Y., Berk, M. P., Singh, L. S., Tan, H., Yin, L., Powell, C. T., & Xu, Y. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-005-8186-4 · Cited by 133
Genomic profiling of malignant melanoma using tiling-resolution arrayCGH
Jönsson, G. B., Dahl, C., Staaf, J., Sandberg, T., Bendahl, P.-O., Ringnér, M., Guldberg, P., & Borg, Å. (2007) · Oncogene · doi:10.1038/sj.onc.1210252 · Cited by 132
Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer
Bastian, B. C. (2003) · Oncogene · doi:10.1038/sj.onc.1206463 · Cited by 130
The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma.
Qin, L., Tang, Z., Sham, J. S. T., C, Z., Ye, S., Zhou, X., Wu, Z.-Q., Trent, J. M., & Guan, X. (1999) · PubMed · Cited by 118
Hsieh, Y., Wu, T.-T., Huang, C., Hsieh, Y., Hwang, J.-M., & Liu, J.-Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2486 · Cited by 115
Gronwald, J., Störkel, S., Holtgreve-Grez, H., Hadaczek, P., Brinkschmidt, C., Jauch, A. T., Lubiński, J., & Cremer, T. J. (1997) · PubMed · Cited by 111
Qi, J., Zhu, Y., Luo, J., & Tao, W. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i44.7113 · Cited by 110
Walter, O., Prasad, M. L., Lu, S., Quinlan, R., Edmiston, K. L., & Khan, A. A. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.05.005 · Cited by 109
A gene expression signature associated with survival in metastatic melanoma
Mandruzzato, S., Callegaro, A., Turcatel, G., Francescato, S., Montesco, M. C., Chiarion‐Sileni, V., D, S. M. M., Rossi, C. R., Bicciato, S., Wang, E., et al. (2006) · Journal of Translational Medicine · doi:10.1186/1479-5876-4-50 · Cited by 108
Genomic imbalances of 7p and 17q in malignant peripheral nerve sheath tumors are clinically relevant
Schmidt, H., W�rl, P., Taubert, H. W., Meye, A., Bache, M., Holzhausen, H. ‐., & Hinze, R. (1999) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199907)25:3<205::aid-gcc2>3.0.co;2-b · Cited by 92
Michiels, S., Danoy, P., Dessen, P., Bera, A., Boulet, T., Bouchardy, C., Lathrop, M. G., Sarasin, A. R., & Benhamou, S. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm111 · Cited by 81
Jiang, Z., Chu, P. G., Woda, B. A., Liu, Q., Balaji, K. C., Rock, K. L., & Wu, C. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0504 · Cited by 79
Han, W., Han, M.-R., Kang, J., Bae, J.-Y., Lee, J., Bae, Y. J., Lee, J. E., Shin, H.-J., Hwang, K., Hwang, S., et al. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-92 · Cited by 69
Cheng, C., Hsieh, H., Sun, C., Lin, C., Luo, S., & Yang, C. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21669 · Cited by 63
Silencing of tissue factor pathway inhibitor‐2 gene in malignant melanomas
Nobeyama, Y., Okochi‐Takada, E., Furuta, J., Miyagi, Y., Kikuchi, K., Yamamoto, A., Nakanishi, Y., Nakagawa, H., & Ushijima, T. (2007) · International Journal of Cancer · doi:10.1002/ijc.22637 · Cited by 62
Association of a Common AKAP9 Variant With Breast Cancer Risk: A Collaborative Analysis
Frank, B., Wiestler, M., Kropp, S., Hemminki, K., Spurdle, A. B., Sutter, C., Wappenschmidt, B., Chen, X., Beesley, J., Hopper, J. L., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn037 · Cited by 53
Effects of fibulin-5 on attachment, adhesion, and proliferation of primary human endothelial cells
Preis, M., Cohen, T., Sarnatzki, Y., Yosef, Y., Schneiderman, J., Gluzman‐Poltorak, Z., Koren, B., Lewis, B. S., Shaul, Y., & Flugelman, M. Y. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.07.156 · Cited by 49
Thomas, J. R., Liu, T., Cotter, M. A., Florell, S. R., Robinette, K., Hanks, A. N., & Grossman, D. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3669 · Cited by 46
A translocation breakpoint disrupts the ASPM gene in a patient with primary microcephaly
Pichon, B., Vankerckhove, S., Bourrouillou, G., Duprez, L., & Abramowicz, M. J. (2004) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201169 · Cited by 36
Cited by
A landscape of driver mutations in melanoma
Hodis, E., Watson, I. R., Kryukov, G. V., Arold, S. T., Imielinski, M., Theurillat, J.-P., Nickerson, E., Auclair, D., Li, L., Place, C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.024 · Cited by 2,610
Self-citationExome sequencing identifies recurrent somatic RAC1 mutations in melanoma
Krauthammer, M., Kong, Y., Ha, B. H., Evans, P., Bacchiocchi, A., McCusker, J. P., Cheng, E., Davis, M. J., Goh, G., Choi, M., et al. (2012) · Nature Genetics · doi:10.1038/ng.2359 · Cited by 1,191
Self-citationLoss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma
Lian, C. G., Xu, Y., Ceol, C., Wu, F., Larson, A., Dresser, K., Xu, W., Tan, L., Hu, Y., Zhan, Q., et al. (2012) · Cell · doi:10.1016/j.cell.2012.07.033 · Cited by 789
Self-citationDiversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis
Rabinovich, S., Adler, L., Yizhak, K., Sarver, A., Silberman, A., Agron, S., Stettner, N., Sun, Q., Brandis, A., Helbling, D., et al. (2015) · Nature · doi:10.1038/nature15529 · Cited by 382
A Systems Biology Approach Identifies FUT8 as a Driver of Melanoma Metastasis
Agrawal, P., Fontanals-Cirera, B., Sokolova, E., Jacob, S., Vaiana, C. A., Argibay, D., Davalos, V., McDermott, M., Nayak, S., Darvishian, F., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.05.007 · Cited by 303
Metadata
- Authors
- Kabbarah, O., Nogueira, C., Feng, B., Nazarian, R. M., Bosenberg, M., Wu, M., Scott, K. L., Kwong, L. N., Xiao, Y., Cordon-Cardo, C., Granter, S. R., Ramaswamy, S., Golub, T., Duncan, L. M., Wagner, S. N., Brennan, C., & Chin, L.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-05-24
- Volume
- 5
- Issue
- 5
- Pages
- e10770
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2125635172
- Cited by
- 261
- References
- 51
- FWCI
- 4.27
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.